Acteon
Acteon is a French medtech company specialising in designing and Manufacturing high-tech dental and medical devices.
It is a leading producer of high-power ultrasound equipment, and also has operations in digital imaging, pharmaceuticals and precision instrumentation.
Acteon is a global player with a presence in more than 100 countries around the world.
- Investment date
- 2019
In 2024
Acteon has demonstrated resilience in a less dynamic market environment. The group continued its policy of innovation aimed at developing new products and meeting the needs of practitioners. In 2024, Acteon and Septodont acquired Inibsa, a global pharmaceutical group based in Spain, specialising in the development and manufacture of products for dentists and dental professionals. Septodont is the controlling shareholder of Inibsa, while Acteon Group is a partner and major shareholder and aims to secure and develop the already existing supply relationship with the Spanish laboratory.
In 2025, Acteon will continue to benefit from its capacity for innovation and from the dental market’s structural growth, driven by rising healthcare expenditure and the emerging middle class in developing countries.
Peugeot Invest's investment
Peugeot Invest, via its wholly owned Peugeot Invest Assets subsidiary, invested €15 million in June 2019 as part of Dentressangle Mid & Large Cap’s acquisition of Acteon and €8 million in October 2024 as part of the financing of the acquisition of Inibsa.
The value of Acteon for the purpose of the Net Asset Value calculation was estimated using the Peugeot Invest group’s policies for valuing unlisted assets. Peugeot Invest Assets, represented by Maxime Bouquet, is a member of Acteon’s Supervisory Committee.
Key figures
- Countries where Acteon is active
- 100